← All companies

ULTA · CIK 1403568

What Ulta Beauty, Inc. told the SEC could break it.

Ulta's sharpest exposure is its reliance on a concentrated set of brand partners: merchandise from its top ten vendors made up about 51% of net sales in fiscal 2025, so amid ongoing beauty-industry vendor consolidation, the loss of or reduced supply from any one key partner could materially hurt results. Its private-label business adds import exposure, with sourcing and manufacturing outside the U.S. that subject it to foreign laws, cross-border shipment disruptions, exchange-rate and import-duty swings and raw-material price increases. And the products it sells — cosmetics including CBD, supplements, OTC drugs, medical devices and styling tools — fall under FDA, FTC, CPSC, EPA and state regulation of safety, labeling, manufacturing and advertising.

3 self-disclosed vulnerabilities, pulled from its own filings — each in the company’s words, with the source. This is the risk register almost nobody reads.

In its own words

What could break it.

Regulatory & policy

  • foreign sourcing and import duties (private-label merchandise)medium

    Ulta's private-label sourcing/manufacturing outside the U.S. exposes it to foreign laws, cross-border shipment disruptions, exchange-rate and import-duty fluctuations, and raw-material price increases.

    sourcing and manufacturing outside the United States, including foreign laws and regulations, political unrest, disruptions or delays in cross-border shipments, changes in economic conditions in foreign countries, exchange rate and import duty fluctuations, and conducting activities with third-party manufacturers; and price increases of raw materials used in the manufacturing of our private label brand merchandise

    SEC filing →As of 2026
  • FDA/FTC/CPSC/EPA product regulation (cosmetics, supplements, OTC drugs, CBD)medium

    Products Ulta sells — cosmetics (incl. CBD), dietary supplements, food, OTC drugs, medical devices and styling tools — are subject to FDA, FTC, CPSC, EPA and state regulation of safety, labeling, manufacturing and advertising.

    The products the Company sells, such as cosmetics (including products with cannabidiol), dietary supplements, food, over-the-counter (“OTC”) drugs, medical devices, and styling tools, including its Ulta Beauty branded products, may be subject to regulation by the U.S. Food and Drug Administration (“FDA”), the U.S. Federal Trade Commission (“FTC”), the Consumer Product Safety Commission (“CPSC”), the Environmental Protection Agency (“EPA”), state regulatory agencies, and State Attorneys General

    SEC filing →As of 2026

Supplier concentration

  • top ten brand partnershigh

    Merchandise from the top ten brand partners was ~51% of net sales in fiscal 2025 (54% prior year); amid beauty-industry vendor consolidation, loss or reduced supply from a key vendor could materially hurt results.

    During fiscal 2025 and fiscal 2024, merchandise supplied by our top ten brand partners accounted for approximately 51% and 54% of our net sales, respectively. There continues to be vendor consolidation within the beauty products industry. The loss of or a reduction in the amount of merchandise made available to us by any one of these key vendors, or by any of our other brand partners, could have a material adverse effect on our business, financial condition, profitability, and cash flows.

    SEC filing →As of 2026

The hidden graph

Who it depends on, and who depends on it.

Relationships surfaced from filings — including ones disclosed by the other side, which is how the non-obvious ones come to light.

Its suppliers

In the MyPRIA app, this is checked against the companies you actually own.

← World Watch